Despite an excellent prognosis (99% survival rate at 20 years), sub-clinical, small, low risk papillary thyroid cancers are often treated aggressively. This review offers an evidence based approach to managing these tumours and looks at the future of alternative surgical techniques and minimally localized invasive therapies such as ethanol ablation and laser ablation.
Brito JP, Hay ID, Morris JC. Low risk papillary thyroid cancer. BMJ 2014;348:g3045 doi:10.1136/bmj.g3045
Endodiabesity 